Glypican-3: a new target for cancer immunotherapy.

Glypican-3: a new target for cancer immunotherapy.
复制标题

DOI:
10.1016/j.ejca.2010.10.024
复制
发表时间:
2011-02
影响因子:
8.4
通讯作者:
Kim, Heungnam
Kim, Heungnam
中科院分区:
医学1区
文献类型:
--
作者:
Ho, Mitchell;Kim, Heungnam

文献摘要

参考文献

被引文献

相似文献

肝细胞癌(HCC)仍然是世界范围内常见的恶性肿瘤。迫切需要确定新的分子靶点以开发新的治疗方法。在此,我们回顾了 Glypican-3 (GPC3) 的结构、功能和生物学及其在人类癌症中的作用,重点关注其作为免疫治疗靶点的潜力。 GPC3 是一种在 HCC 中过度表达的细胞表面蛋白。 GPC3 的功能丧失突变会导致 Simpson-Golabi-Behmel 综合征,这是一种罕见的 X 连锁过度生长病症。 GPC3 结合 Wnt 和 Hedgehog 信号蛋白。 GPC3 还能够通过其硫酸乙酰肝素聚糖链结合碱性生长因子,例如成纤维细胞生长因子 2。鉴于 GPC3 在 HCC 中表现出高表达,因此它是肝癌治疗的有希望的候选者。一种抗GPC3单克隆抗体在小鼠中显示出抗癌活性,其人源化IgG分子目前正在HCC患者中进行临床评估。还有证据表明可溶性 GPC3 可能是 HCC 的有用血清生物标志物。
Hepatocellular carcinoma (HCC) remains a common malignant cancer worldwide. There is an urgent need to identify new molecular targets for the development of novel therapeutic approaches. Here, we review the structure, function and biology of Glypican-3 (GPC3) and its role in human cancer with a focus on its potential as a therapeutic target for immunotherapy. GPC3 is a cell-surface protein that is over-expressed in HCC. Loss-of-function mutations of GPC3 cause Simpson-Golabi-Behmel syndrome, a rare X-linked overgrowth condition. GPC3 binds Wnt and Hedgehog signaling proteins. GPC3 is also able to bind basic growth factors such as fibroblast growth factor 2 through its heparan sulfate glycan chains. GPC3 is a promising candidate for liver cancer therapy given that it shows high expression in HCC. An anti-GPC3 monoclonal antibody has shown anti-cancer activity in mice and its humanized IgG molecule is currently undergoing clinical evaluation in patients with HCC. There is also evidence that soluble GPC3 may be a useful serum biomarker for HCC.
DOI: 10.1165/rcmb.2003-0061oc
发表时间: 2003-12-01
影响因子: 6.4
作者:
Kim, H;Xu, GL;Powell, CA
通讯作者: Powell, CA
DOI: 10.1158/0008-5472.can-08-1973
发表时间: 2008-12-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Ishiguro, Takahiro;Sugimoto, Masamichi;Yamada-Okabe, Hisafumi
通讯作者: Yamada-Okabe, Hisafumi
DOI: 10.1002/ijc.10856
发表时间: 2003-02-10
影响因子: 6.4
作者:
Midorikawa, Y;Ishikawa, S;Aburatani, H
通讯作者: Aburatani, H
DOI: 10.1093/carcin/bgn091
发表时间: 2008-07
期刊: Carcinogenesis
影响因子: 4.7
作者:
Cheng W;Tseng CJ;Lin TT;Cheng I;Pan HW;Hsu HC;Lee YM
通讯作者: Lee YM
DOI: 10.1016/j.devcel.2008.03.006
发表时间: 2008-05-01
期刊: DEVELOPMENTAL CELL
影响因子: 11.8
作者:
Capurro, Mariana I.;Xu, Ping;Filmus, Jorge
通讯作者: Filmus, Jorge